KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Liabilities and Shareholders Equity (2016 - 2025)

Teladoc Health's Liabilities and Shareholders Equity history spans 12 years, with the latest figure at $2.9 billion for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 18.42% year-over-year to $2.9 billion; the TTM value through Dec 2025 reached $9.2 billion, down 38.1%, while the annual FY2024 figure was $3.5 billion, 19.94% down from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $2.9 billion at Teladoc Health, down from $2.9 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $17.7 billion in Q4 2021 and bottomed at $2.9 billion in Q3 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $4.3 billion (2022), against an average of $7.7 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity soared 996.79% in 2021 before it plummeted 75.5% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $17.7 billion in 2021, then tumbled by 75.5% to $4.3 billion in 2022, then grew by 1.08% to $4.4 billion in 2023, then dropped by 19.94% to $3.5 billion in 2024, then dropped by 18.14% to $2.9 billion in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Liabilities and Shareholders Equity are $2.9 billion (Q3 2025), $2.9 billion (Q2 2025), and $3.4 billion (Q1 2025).